A very recent study analyzing the prevalence of germline cancer susceptibility variants in patients with periampullary cancers showed that among 69 patients with duodenal cancer, 9 had a pathogenic germline variant, including three with a pathogenic/likely pathogenic germline variant in BRCA2. This evidence concerns the gene BRCA2 and cancer.